The second-generation of highly potent hepatitis C virus (HCV) NS3/4A protease inhibitors: Evolutionary design based on tailor-made amino acids, synthesis and major features of bio-activity

  1. Wang, S.
  2. Wang, Y.
  3. Wang, J.
  4. Sato, T.
  5. Izawa, K.
  6. Soloshonok, V.A.
  7. Liu, H.
Revue:
Current Pharmaceutical Design

ISSN: 1873-4286 1381-6128

Année de publication: 2017

Volumen: 23

Número: 30

Pages: 4493-4554

Type: Révision

DOI: 10.2174/1381612823666170522122424 GOOGLE SCHOLAR

Objectifs de Développement Durable